Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 29

1.

Nuclear factor-kappa B regulates pain and COMT expression in a rodent model of inflammation.

Hartung JE, Eskew O, Wong T, Tchivileva IE, Oladosu FA, O'Buckley SC, Nackley AG.

Brain Behav Immun. 2015 Jul 15. pii: S0889-1591(15)00409-2. doi: 10.1016/j.bbi.2015.07.014. [Epub ahead of print]

PMID:
26187567
2.

MicroRNA expression profiles differentiate chronic pain condition subtypes.

Ciszek BP, Khan AA, Dang H, Slade GD, Smith S, Bair E, Maixner W, Zolnoun D, Nackley AG.

Transl Res. 2015 Jun 24. pii: S1931-5244(15)00213-3. doi: 10.1016/j.trsl.2015.06.008. [Epub ahead of print]

PMID:
26166255
3.

Genetic Variants in Cyclooxygenase-2 Contribute to Post-treatment Pain among Endodontic Patients.

Applebaum E, Nackley AG, Bair E, Maixner W, Khan AA.

J Endod. 2015 Aug;41(8):1214-8. doi: 10.1016/j.joen.2015.04.021. Epub 2015 Jun 14.

PMID:
26081267
4.

Catechol-O-methyltransferase inhibition alters pain and anxiety-related volitional behaviors through activation of β-adrenergic receptors in the rat.

Kline RH 4th, Exposto FG, O'Buckley SC, Westlund KN, Nackley AG.

Neuroscience. 2015 Apr 2;290:561-9. doi: 10.1016/j.neuroscience.2015.01.064. Epub 2015 Feb 7.

PMID:
25659347
5.

Epistasis between polymorphisms in COMT, ESR1, and GCH1 influences COMT enzyme activity and pain.

Smith SB, Reenilä I, Männistö PT, Slade GD, Maixner W, Diatchenko L, Nackley AG.

Pain. 2014 Nov;155(11):2390-9. doi: 10.1016/j.pain.2014.09.009. Epub 2014 Sep 16.

PMID:
25218601
6.

β2- and β3-adrenergic receptors drive COMT-dependent pain by increasing production of nitric oxide and cytokines.

Hartung JE, Ciszek BP, Nackley AG.

Pain. 2014 Jul;155(7):1346-55. doi: 10.1016/j.pain.2014.04.011. Epub 2014 Apr 13.

7.

Excess risk of temporomandibular disorder associated with cigarette smoking in young adults.

Sanders AE, Maixner W, Nackley AG, Diatchenko L, By K, Miller VE, Slade GD.

J Pain. 2012 Jan;13(1):21-31. doi: 10.1016/j.jpain.2011.08.003. Epub 2011 Oct 26.

8.

Cytokine biomarkers and chronic pain: association of genes, transcription, and circulating proteins with temporomandibular disorders and widespread palpation tenderness.

Slade GD, Conrad MS, Diatchenko L, Rashid NU, Zhong S, Smith S, Rhodes J, Medvedev A, Makarov S, Maixner W, Nackley AG.

Pain. 2011 Dec;152(12):2802-12. doi: 10.1016/j.pain.2011.09.005. Epub 2011 Oct 14.

9.

Comt1 genotype and expression predicts anxiety and nociceptive sensitivity in inbred strains of mice.

Segall SK, Nackley AG, Diatchenko L, Lariviere WR, Lu X, Marron JS, Grabowski-Boase L, Walker JR, Slade G, Gauthier J, Bailey JS, Steffy BM, Maynard TM, Tarantino LM, Wiltshire T.

Genes Brain Behav. 2010 Nov;9(8):933-46. doi: 10.1111/j.1601-183X.2010.00633.x.

10.

A novel alternatively spliced isoform of the mu-opioid receptor: functional antagonism.

Gris P, Gauthier J, Cheng P, Gibson DG, Gris D, Laur O, Pierson J, Wentworth S, Nackley AG, Maixner W, Diatchenko L.

Mol Pain. 2010 Jun 2;6:33. doi: 10.1186/1744-8069-6-33.

11.

Quantification of condylar resorption in temporomandibular joint osteoarthritis.

Cevidanes LH, Hajati AK, Paniagua B, Lim PF, Walker DG, Palconet G, Nackley AG, Styner M, Ludlow JB, Zhu H, Phillips C.

Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2010 Jul;110(1):110-7. doi: 10.1016/j.tripleo.2010.01.008. Epub 2010 Apr 9.

12.
13.

Signaling pathways mediating beta3-adrenergic receptor-induced production of interleukin-6 in adipocytes.

Tchivileva IE, Tan KS, Gambarian M, Nackley AG, Medvedev AV, Romanov S, Flood PM, Maixner W, Makarov SS, Diatchenko L.

Mol Immunol. 2009 Jul;46(11-12):2256-66. doi: 10.1016/j.molimm.2009.04.008. Epub 2009 May 23.

14.

Low enzymatic activity haplotypes of the human catechol-O-methyltransferase gene: enrichment for marker SNPs.

Nackley AG, Shabalina SA, Lambert JE, Conrad MS, Gibson DG, Spiridonov AN, Satterfield SK, Diatchenko L.

PLoS One. 2009;4(4):e5237. doi: 10.1371/journal.pone.0005237. Epub 2009 Apr 13.

15.

Characterization of NF-kB-mediated inhibition of catechol-O-methyltransferase.

Tchivileva IE, Nackley AG, Qian L, Wentworth S, Conrad M, Diatchenko LB.

Mol Pain. 2009 Mar 16;5:13. doi: 10.1186/1744-8069-5-13.

16.

Genetic architecture of human pain perception.

Diatchenko L, Nackley AG, Tchivileva IE, Shabalina SA, Maixner W.

Trends Genet. 2007 Dec;23(12):605-13. Epub 2007 Nov 26. Review.

PMID:
18023497
18.

Human catechol-O-methyltransferase haplotypes modulate protein expression by altering mRNA secondary structure.

Nackley AG, Shabalina SA, Tchivileva IE, Satterfield K, Korchynskyi O, Makarov SS, Maixner W, Diatchenko L.

Science. 2006 Dec 22;314(5807):1930-3.

19.

Catechol-O-methyltransferase inhibition increases pain sensitivity through activation of both beta2- and beta3-adrenergic receptors.

Nackley AG, Tan KS, Fecho K, Flood P, Diatchenko L, Maixner W.

Pain. 2007 Apr;128(3):199-208. Epub 2006 Nov 7.

20.

Beta2 adrenergic receptor activation stimulates pro-inflammatory cytokine production in macrophages via PKA- and NF-kappaB-independent mechanisms.

Tan KS, Nackley AG, Satterfield K, Maixner W, Diatchenko L, Flood PM.

Cell Signal. 2007 Feb;19(2):251-60. Epub 2006 Sep 20.

PMID:
16996249
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk